Ascentage Pharma Group International (OTCMKTS:ASPHF) Sees Significant Growth in Short Interest

Ascentage Pharma Group International (OTCMKTS:ASPHF) was the target of a large increase in short interest during the month of January. As of January 31st, there was short interest totalling 1,946,100 shares, an increase of 25.5% from the January 15th total of 1,551,100 shares. Based on an average daily volume of 200 shares, the days-to-cover ratio is presently 9,730.5 days.

Ascentage Pharma Group International Stock Performance

Ascentage Pharma Group International stock remained flat at $5.83 during trading hours on Friday. Ascentage Pharma Group International has a 1 year low of $5.42 and a 1 year high of $6.45. The firm’s fifty day moving average price is $6.22 and its 200-day moving average price is $4.83.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.